Moderna and Merck’s Melanoma Breakthrough | Rochester News

Rochester News Today | 2 Min News | The Daily News Now! · Aug 23, 2026 · 1m

Moderna and Merck just dropped some major news on melanoma treatment—early trial results show a custom mRNA vaccine, paired with Keytruda, slashed the risk of death by nearly half for advanced-stage patients. This isn’t your average therapy: scientists sequence your tumor’s DNA, design a personalized vaccine to train your immune system to hunt down cancer cells, and it’s already showing life-changing promise. Not FDA-approved yet, but doctors are calling it a potential game-changer for those who’ve run out of options. Side effects and cost remain unknown—but when you’re talking about turning…